BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morgan J, Muntoni F. Changes in Myonuclear Number During Postnatal Growth -Implications for AAV Gene Therapy for Muscular Dystrophy. J Neuromuscul Dis 2021. [PMID: 34334413 DOI: 10.3233/JND-210683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bateman-House A, Shah LD, Escandon R, McFadyen A, Hunt C. Somatic Gene Therapy Research in Pediatric Populations: Ethical Issues and Guidance for Operationalizing Early Phase Trials. Pharmaceut Med 2023;37:17-24. [PMID: 36527677 DOI: 10.1007/s40290-022-00451-x] [Reference Citation Analysis]
2 Ramamurthy RM, Rodriguez M, Ainsworth HC, Shields J, Meares D, Bishop C, Farland A, Langefeld CD, Atala A, Doering CB, Spencer HT, Porada CD, Almeida-Porada G. Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII. Front Immunol 2022;13:954984. [PMID: 36591257 DOI: 10.3389/fimmu.2022.954984] [Reference Citation Analysis]
3 Hildyard JCW, Riddell DO, Harron RCM, Rawson F, Foster EMA, Massey C, Taylor-Brown F, Wells DJ, Piercy RJ. The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy. Wellcome Open Res 2022;7:238. [PMID: 36865375 DOI: 10.12688/wellcomeopenres.18251.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Meng J, Moore M, Counsell J, Muntoni F, Popplewell L, Morgan J. Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy. Mol Ther Methods Clin Dev 2022;25:491-507. [PMID: 35615709 DOI: 10.1016/j.omtm.2022.04.015] [Reference Citation Analysis]